LYFIX vs. FBTCX
Compare and contrast key facts about AlphaCentric LifeSci Healthcare Fund (LYFIX) and Fidelity Advisor Biotechnology Fund Class C (FBTCX).
LYFIX is managed by AlphaCentric Funds. It was launched on Nov 28, 2019. FBTCX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
LYFIX vs. FBTCX - Performance Comparison
Loading graphics...
LYFIX vs. FBTCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
LYFIX AlphaCentric LifeSci Healthcare Fund | -0.31% | 28.22% | -0.27% | 7.19% | -0.92% | -3.42% | 54.83% | 1.20% |
FBTCX Fidelity Advisor Biotechnology Fund Class C | 2.09% | 38.48% | -2.00% | 9.86% | -8.64% | -3.72% | 31.17% | 2.87% |
Returns By Period
In the year-to-date period, LYFIX achieves a -0.31% return, which is significantly lower than FBTCX's 2.09% return.
LYFIX
- 1D
- 4.07%
- 1M
- -3.00%
- YTD
- -0.31%
- 6M
- 16.38%
- 1Y
- 26.02%
- 3Y*
- 8.51%
- 5Y*
- 4.83%
- 10Y*
- —
FBTCX
- 1D
- 5.09%
- 1M
- -0.81%
- YTD
- 2.09%
- 6M
- 15.10%
- 1Y
- 54.26%
- 3Y*
- 17.00%
- 5Y*
- 6.73%
- 10Y*
- 10.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LYFIX vs. FBTCX - Expense Ratio Comparison
LYFIX has a 1.40% expense ratio, which is lower than FBTCX's 1.75% expense ratio.
Return for Risk
LYFIX vs. FBTCX — Risk / Return Rank
LYFIX
FBTCX
LYFIX vs. FBTCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AlphaCentric LifeSci Healthcare Fund (LYFIX) and Fidelity Advisor Biotechnology Fund Class C (FBTCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LYFIX | FBTCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.25 | 1.90 | -0.65 |
Sortino ratioReturn per unit of downside risk | 1.79 | 2.49 | -0.70 |
Omega ratioGain probability vs. loss probability | 1.22 | 1.32 | -0.10 |
Calmar ratioReturn relative to maximum drawdown | 2.36 | 3.08 | -0.72 |
Martin ratioReturn relative to average drawdown | 5.75 | 12.19 | -6.45 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| LYFIX | FBTCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.25 | 1.90 | -0.65 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.21 | 0.29 | -0.08 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.42 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.51 | 0.27 | +0.24 |
Correlation
The correlation between LYFIX and FBTCX is 0.84, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
LYFIX vs. FBTCX - Dividend Comparison
LYFIX's dividend yield for the trailing twelve months is around 1.79%, more than FBTCX's 1.65% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LYFIX AlphaCentric LifeSci Healthcare Fund | 1.79% | 1.78% | 2.24% | 2.63% | 4.43% | 12.88% | 2.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FBTCX Fidelity Advisor Biotechnology Fund Class C | 1.65% | 1.68% | 0.00% | 0.00% | 0.00% | 24.50% | 9.78% | 7.92% | 2.92% | 0.00% | 0.00% | 5.73% |
Drawdowns
LYFIX vs. FBTCX - Drawdown Comparison
The maximum LYFIX drawdown since its inception was -35.33%, smaller than the maximum FBTCX drawdown of -64.04%. Use the drawdown chart below to compare losses from any high point for LYFIX and FBTCX.
Loading graphics...
Drawdown Indicators
| LYFIX | FBTCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.33% | -64.04% | +28.71% |
Max Drawdown (1Y)Largest decline over 1 year | -9.47% | -13.63% | +4.16% |
Max Drawdown (5Y)Largest decline over 5 years | -32.45% | -37.26% | +4.81% |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.37% | — |
Current DrawdownCurrent decline from peak | -3.88% | -2.75% | -1.13% |
Average DrawdownAverage peak-to-trough decline | -10.07% | -23.21% | +13.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.24% | 3.75% | +0.49% |
Volatility
LYFIX vs. FBTCX - Volatility Comparison
The current volatility for AlphaCentric LifeSci Healthcare Fund (LYFIX) is 7.96%, while Fidelity Advisor Biotechnology Fund Class C (FBTCX) has a volatility of 9.37%. This indicates that LYFIX experiences smaller price fluctuations and is considered to be less risky than FBTCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| LYFIX | FBTCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.96% | 9.37% | -1.41% |
Volatility (6M)Calculated over the trailing 6-month period | 13.70% | 17.02% | -3.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.38% | 25.99% | -6.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.93% | 23.48% | -0.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.50% | 24.66% | -1.16% |